Veredus Laboratories, a private Singapore company, announced in Singapore on Thursday July 28 the launch of three diagnostic kits for avian influenza, malaria and dengue fever.
Being the first commercially available bird flu diagnostic kit in the world, the Veredus’ kit can detect a gene specific to the H5N1 strain in less than four hours.
Its effectiveness has been proved by tests in Vietnam and Malaysia, which showed no cross reactivity to other pathogens.
The DNA-based malaria diagnostic kit is able to confirm the malaria infection and identify the specific species of the parasite early and rapidly with just a drop of blood from a patient.
Having been used for over three-years in Singapore’s National University Hospital, the dengue fever kit is able to detect the virus from the second day of infection, at least three days earlier than conventional tests do.
All the three diagnostic kits were developed by using technologies licensed from the National University of Singapore and the Agency for Science, Technology and Research.
Being confident about the market response to these kits, Veredus expects to release more DNA-based tests for other infectious diseases in the near future.
Statistics show that there are about 500 million malaria cases and 50 million dengue cases all over the world per year, while the bird flu virus is mutating rapidly and poses a clear danger to human beings.